What is osteoporosis, and why is it called the “silent disease”?
Osteoporosis is a systemic bone disease characterized by a decrease in bone mineral density and an alteration in trabecular microarchitecture—two factors that exponentially increase the risk of fractures. It is called the “silent disease” because it progresses without symptoms for years, until a fracture reveals the bone’s fragility. For preventive supplements, see our line of bone remineralizers.
- Indicator fractures: hip (1-year mortality: 20–30%), vertebrae (often asymptomatic compression fractures), wrist (fall onto an outstretched hand)—any fracture occurring after minor trauma should raise suspicion of underlying osteoporosis
- Silent vertebral fractures: Two-thirds of osteoporotic vertebral compression fractures are painless—discovered incidentally on X-rays—but they lead to progressive loss of height and promote kyphosis (“hunchback”)
- T-score ≤ -2.5 on DEXA: diagnostic threshold—between -1 and -2.5 = osteopenia (ideal preventive stage for intervention)—see our page on fractures
- Osteoporosis in men: 20% of patients with osteoporosis are men—underdiagnosed because they are less closely monitored—low testosterone + corticosteroids + alcohol = main risk factors
What are the risk factors and medical conditions that contribute to osteoporosis?
Beyond age and menopause, numerous medical and medication-related factors increase the risk of secondary osteoporosis—which must be identified for early management.
- Long-term corticosteroid therapy: the leading iatrogenic risk factor for osteoporosis—starting at 3 months of corticosteroids at a dose of ≥ 7.5 mg/day of prednisone; systematic calcium and vitamin D3 supplementation is recommended
- Intestinal malabsorption: celiac disease, IBD, bariatric surgery—insufficient absorption of calcium and vitamin D—routine bone assessment
- Hyperparathyroidism: excessive stimulation of osteoclasts by PTH — accelerated bone loss regardless of age
- Untreated hyperthyroidism: accelerated bone remodeling with net loss—thyroid treatment partially restores bone density
- Other causes: type 1 diabetes (impaired bone collagen quality), anorexia nervosa (nutritional deprivation + amenorrhea), prolonged immobilization
What supplements can help prevent and manage osteoporosis?
Supplementation is the non-pharmacological cornerstone of osteoporosis treatment—to be combined with prescribed medical treatments for optimal effectiveness. Find these formulas in our calcium and vitamin D product lines.
- Calcium: 1,000–1,500 mg/day depending on individual needs—calcium citrate is preferred for seniors and those taking PPIs (absorption is not affected by stomach acid)—maximum 500 mg per dose
- Vitamin D3: Maintain levels of ≥ 30 ng/mL—in cases of confirmed osteoporosis, 1,500–2,000 IU/day or even more in cases of severe deficiency—annual blood test recommended
- Vitamin K2 (MK-7): activates osteocalcin and directs calcium to the bones — reduces the risk of arterial calcification associated with calcium supplements — 100–200 μg/day
- Magnesium: a cofactor for vitamin D3 and a component of hydroxyapatite—300–400 mg/day
- Organic silicon: stimulates bone collagen synthesis — improves the quality of the protein matrix beyond just mineral density
What medical treatments are available for diagnosed osteoporosis?
Medical treatments for osteoporosis significantly reduce the risk of fractures—they should always be combined with calcium and vitamin D3 supplements for optimal effectiveness.
- Bisphosphonates (alendronate, risedronate, zoledronate): inhibit osteoclasts—40–70% reduction in vertebral fractures—first-line treatment—taken orally in the morning on an empty stomach with a large glass of water; remain standing for 30 minutes
- Denosumab: anti-RANK-L antibody—subcutaneous injection every 6 months—powerful anti-resorptive agent—gradual tapering required (risk of fracture rebound)
- Teriparatide: recombinant PTH — bone anabolic (stimulates bone formation) — reserved for severe osteoporosis with multiple fractures
- Calcium + Vitamin D3: mandatory in combination with all medical treatments for osteoporosis—their absence significantly reduces efficacy
- Hormone replacement therapy (HRT): protects bone mass if prescribed within the first 10 years — an individualized medical decision to be made with a gynecologist or endocrinologist
